Sharemaestro Newsreel

Align Technology (NASDAQ:ALGN) Reports Q2 CY2026 In Line With Expectations But Quarterly Revenue Guidance Slightly Misses Expectations

Align Technology (NASDAQ:ALGN) reported Q2 CY2026 revenue of $1.06 billion, meeting Wall Street expectations with a 4.3% year-on-year increase, and adjusted EPS of $2.64, beating estimates. However, its Q3 CY2026 revenue guidance of $1.01 billion slightly missed analysts' estimates. Despite a strong Q2 performance …

MIMEDX Announces Second Quarter 2026 Operating & Financial Results

Reports Second Quarter Net Sales of $64 Million Reiterates Full Year Financial Outlook on a Standalone Basis Announces Plans to Acquire Sanara MedTech Management to Host Conference Call Today, July 29, 2026, at 4:30 PM ET MARIETTA, Ga., July 29, 2026 (GLOBE NEWSWIRE) -- …

BlackRock (NYSE: BLK) discloses 5.6% beneficial stake in KORU Medical Systems (KRMD)

BlackRock, Inc. has filed a Schedule 13G disclosing a 5.6% beneficial ownership stake in KORU Medical Systems (KRMD), amounting to 2,575,761 shares of common stock. The filing indicates BlackRock has sole voting power over 2,537,482 shares and sole dispositive power over all 2,575,761 shares. …

Avantor (AVTR) Stock Climbs As Analysts Hike Targets Ahead Q2

Avantor (AVTR) stock has climbed by 13.77% after analysts from firms like BofA, TD Cowen, Citi, and Evercore ISI hiked their price targets ahead of its Q2 2026 earnings release. While most firms maintain a Neutral/Hold rating, the increased targets and positive macro trends …

Avantor Inc (AVTR) Q2 2026 Earnings Call Highlights: Strategic Growth and Financial Resilience

This article first appeared on GuruFocus. Revenue: $1.69 billion, declined 0.4% organically, up 0.5% on a reported basis. VWR Segment Revenue: $1.24 billion, up 1.7% organically. BMP Segment Revenue: $452 million, down 5.6% organically. Adjusted EBITDA: $254 million, margin of 15%. Adjusted Earnings Per …

Envista to Host Investor Day on September 17, 2026

Envista Holdings Corporation (NYSE: NVST) announced it will host an Investor Day on Thursday, September 17, 2026, from 9:00 a.m. to noon EDT. The event will feature a management presentation and a Q&A session, accessible via live webcast and replay on the company's investor …

EMBC INVESTOR ALERT: Embecta Corp. (EMBC) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit- Hagens Berman

Hagens Berman has initiated an investigation into Embecta Corp. (EMBC) following a class action lawsuit alleging misrepresentation of the commercial stability of its insulin pen needle business. The lawsuit claims Embecta misled investors about market share loss and volume softness, which led to a …

XRAY Maintained by Piper Sandler -- Price Target Raised to $14.0

Piper Sandler has maintained a Neutral rating for Dentsply Sirona (XRAY) and raised its price target from $13.00 to $14.00, signaling cautious optimism for the company's future. Despite current unprofitability, XRAY is considered 26.3% undervalued according to its GF Value™ of $18.99, and insider …

Solventum Corp stock hits 52-week high at 88.21 USD

Solventum Corp's stock has reached a 52-week high of $88.21, reflecting positive investor sentiment and a 20.57% increase over the past year. The healthcare technology firm, with a market capitalization of $14.92 billion, reported strong Q1 2026 earnings, surpassing expectations, and received an Outperform …

SOLN5759814 Bond Profile — Key Metrics

This article provides key metrics for the Solventum Corporation bond, SOLN5759814, which has a 5.45% coupon rate and matures on March 13, 2031. The bond was issued on February 27, 2024, with an outstanding amount of $1.21 million. Solventum Corp. operates as a healthcare …

Teleflex Number of Employees 2026 | Employee Count & Headcount Data

Teleflex, Inc. (TFX) had approximately 15,496 employees worldwide as of March 2026, marking a 3.2% growth from 2023. The company, headquartered in Wayne, Pennsylvania, is actively hiring with 295 job postings in 2026, though hiring velocity has declined. Its workforce is primarily concentrated in …

MiMedx agrees to buy Sanara MedTech for $35 a share (SMTI:NASDAQ)

MiMedx has announced an agreement to acquire Sanara MedTech for $35 per share. The deal will provide Sanara shareholders with $33.00 in cash and 0.4735 shares of MiMedx common stock for each share they own. This acquisition represents a significant merger in the medical …

Align Technology earnings up next: Growth momentum in focus By Investing.com

Align Technology (ALGN) is set to report its second-quarter results, with analysts expecting modest year-over-year gains in EPS and revenue. Despite a bullish stance from Wall Street and a growing clear aligners market, some caution exists as EPS and revenue estimates have slightly declined. …

Repligen Beats Q2 Earnings Estimates, Raises 2026 View, Stock Up

Repligen (RGEN) reported strong second-quarter 202

Avantor Stock Climbs As Analysts Hike Targets And NuSil Expands

Avantor Inc. (AVTR) stock has risen by 14.21% due to strong demand in life sciences and company expansion, with analysts raising price targets into the $10.50-$12 range. The company's NuSil brand is expanding its partnership with the Population Council on an HIV prevention ring. …

Price to sales forward of Femasys Inc. – NASDAQ:FEMY

This article provides a brief financial overview of Femasys Inc. (NASDAQ: FEMY), specifically focusing on its forward price-to-sales ratio. It appears to be a stub or snippet from a larger financial data platform like TradingView, indicating where more detailed financial information can be found …

Baxter earnings loom as company unveils new segment structure

Baxter International Inc. is set to report its second-quarter earnings, debuting a new streamlined reporting structure. Analysts anticipate adjusted earnings of 37 cents per share on revenue of $2.8 billion, with a cautious "Hold" rating from most analysts despite recent price target increases. Investors …

Why Repligen (RGEN) Stock Is Up Today

Shares of Repligen Corporation (NASDAQ: RGEN) rose significantly after the biopharma manufacturing company reported strong second-quarter results, beating analyst expectations for both adjusted earnings and revenue. The company also raised its full-year guidance, signaling confidence in its continued performance. This positive news contrasts with …

Kaplan Fox Notifies Embecta Corp. (EMBC) Investors of a Securities Class Action Deadline on August 17, 2026

Kaplan Fox & Kilsheimer LLP has announced a securities class action lawsuit against Embecta Corp. (EMBC) for investors who purchased securities between November 25, 2025, and May 4, 2026. The lawsuit stems from Embecta's Q2 fiscal 2026 results, which were significantly below expectations, leading …

L1 Capital Executes Significant Share Sales, Reducing Stake in Anteris Technologies (NASDAQ: AVR)

L1 Capital Pty Ltd, a director of Anteris Technologies Global Corp. (NASDAQ: AVR), sold over 441,000 shares of the company's common stock in late July 2026. The sales occurred across two trading days at prices between $7.90 and $8.42 per share. This disclosure indicates …

Pulse Biosciences Surpasses Enrollment Midpoint in NANOPULSE-AF IDE Pivotal Study

Pulse Biosciences has announced that its NANOPULSE-AF IDE Pivotal Study, investigating its Nanosecond Pulsed Field Ablation (nano-PFA) technology for atrial fibrillation, has surpassed its enrollment midpoint since commencing in April 2026. The rapid enrollment is attributed to the enthusiasm of investigational sites for the …

Pulse Biosciences Reaches Enrollment Midpoint in NANOPULSE-AF Trial for Cardiac Treatment

Pulse Biosciences announced that its NANOPULSE-AF clinical study has reached its enrollment midpoint for the nPulse Cardiac Catheter System. This pivotal study is evaluating the technology for treating recurrent, drug-resistant, symptomatic paroxysmal atrial fibrillation. The achievement marks a significant step towards potential regulatory approval …

EMBC Deadline Alert: Levi & Korsinsky Reminds Embecta Corp. (EMBC) Investors of Securities Class Action Deadline on August 17, 2026

Levi & Korsinsky, LLP is reminding investors of Embecta Corp. (NASDAQ: EMBC) about a securities class action lawsuit with a lead plaintiff deadline of August 17, 2026. The lawsuit alleges that Embecta made misrepresentations regarding the stability of its U.S. pen needle revenue, which …

Align Technology to overhaul board following engagement with Elliott

Align Technology announced it will add three independent directors to its board and launch a comprehensive operational review after discussions with activist investor Elliott Investment Management. The strategic changes aim to improve revenue growth and boost profit margins, and the company also increased its …

Did Dentsply Sirona Inc. Insiders Breach their Fiduciary Duties to Shareholders?

Halper Sadeh LLC, an investor rights law firm, is investigating whether officers and directors of Dentsply Sirona Inc. (NASDAQ: XRAY) breached their fiduciary duties to shareholders. The firm encourages long-term shareholders to contact them to discuss legal options, including seeking corporate governance reforms or …

Avantor (AVTR) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates

For the quarter ended June 2026, Avantor, Inc. (AVTR) reported revenue of $1.69 billion, up 0.5% over the same period last year. EPS came in at $0.21, compared to $0.24 in the year-ago quarter. The reported revenue represents a surprise of +4.17% over the …

Repligen Earnings: Excellent Profit Margins, China Recovery Underway

Avantor, Inc. Q2 2026: Revenue $1.69B, EPS $0.06— 10-Q Summary

Avantor, Inc. reported Q2 2026 results with revenue of $1.69 billion, nearly flat year-over-year, and diluted EPS of $0.06, down from $0.09 in the prior year. The company experienced margin pressure and mixed demand, leading to a decline in net income. While VWR Distribution …

Bausch + Lomb Corporation Raises Earnings Guidance for the Full Fiscal Year 2026

Bausch + Lomb Corporation has updated its earnings guidance for the full fiscal year 2026, raising its revenue expectations. The company now anticipates revenue to fall between $5.440 billion and $5.540 billion, an increase from its previous forecast of $5.420 billion to $5.520 billion.

KORU Medical Systems (KRMD) Expected to Announce Quarterly Earnings on Wednesday

KORU Medical Systems (NASDAQ:KRMD) is anticipated to release its Q2 2026 earnings after the market closes on Wednesday, August 5th. Analysts project the company will report a loss of $0.02 per share and revenue of approximately $11.6 million. The company's shares opened at $4.01, …

Repligen Offers Differentiated Solutions as a Leading Bioprocessing Supplier

Repligen is highlighted as a leading provider of bioprocessing solutions for biologic drug manufacturers. The company offers a range of advanced systems including filtration, fluid management, chromatography columns, and process analytics. Despite its relatively small size, Repligen is noted for its innovation and record …

Avantor Releases Q2 2026 Financial Results

Avantor, Inc. reported Q2 2026 adjusted earnings per share of $0.21, surpassing analyst estimates by 10.5%. The company achieved $1.69 billion in revenue, a slight increase from Q2 2025, despite a 0.4% decline in organic revenue due to biopharma and research market headwinds. Avantor …

ETFs Investing in AtriCure, Inc. Stocks

This article lists various Exchange Traded Funds (ETFs) that hold shares of AtriCure, Inc. (ATRC). It provides a comprehensive table detailing each fund's market value, weight of ATRC stock, issuer, management style, focus, expense ratio, assets under management (AUM), price, change, relative volume, and …

Canaccord reiterates Hold on Repligen stock, keeps $145 target

Canaccord Genuity has reiterated a Hold rating on Repligen Corp. (NASDAQ:RGEN) and maintained its $145 price target, believing the shares are fairly valued. The bioprocessing company exceeded analyst expectations for its second-quarter 2026 results, reporting strong revenue growth across all franchises and raising its …

Femasys Inc (FEMY) Risk Assessment: Volatility, Financial Risk & Investment Risk

This article assesses the risk profile of Femasys Inc (FEMY), highlighting its current risk assessment score of 1.28, which ranks it 184th out of 199 companies in the Healthcare Equipment & Supplies industry. Key metrics include a beta value of -2.13, indicating defensive stock …

Earnings Flash (BLCO) Bausch + Lomb Corporation Posts Q2 Adjusted EPS $0.15 per Share, Vs. FactSet Est of $0.15

Bausch + Lomb Corporation (BLCO) announced its Q2 adjusted earnings per share (EPS) of $0.15, meeting FactSet's estimate. This financial report provides key insights into the company's performance for the second quarter.